FDA Approved: ABREVA — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for ABREVA (docosanol) submitted by Haleon US Holdings LLC. ABREVA is an OTC topical treatment for herpes simplex labial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Labialis

Drugs mentioned

• ABREVA (Docosanol)

Snippet

SUPPL AP for ABREVA (DOCOSANOL)